Verrica Pharmaceuticals Inc. (VRCA)

Verrica Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	317	308	113	252	298	410
Market Cap Growth	-7.69%	172.47%	-55.17%	-15.33%	-27.31%	95.57%
Enterprise Value	314	284	80	225	269	348
PE Ratio	-	-4.60	-4.61	-7.19	-6.97	-14.52
PS Ratio	35.55	60.09	12.51	21.01	-	-
PB Ratio	210.13	15.58	2.82	7.73	9.03	6.30
P/FCF Ratio	-4.63	-7.91	-5.96	-8.86	-9.40	-14.58
P/OCF Ratio	-4.66	-7.98	-6.06	-9.14	-9.86	-14.94
EV/Sales Ratio	35.27	55.40	8.89	18.76	-	-
EV/EBITDA Ratio	-3.38	-4.56	-3.72	-7.43	-6.83	-12.44
EV/EBIT Ratio	-3.34	-4.50	-3.60	-7.31	-6.79	-12.33
EV/FCF Ratio	-4.58	-7.29	-4.23	-7.91	-8.51	-12.38
Debt / Equity Ratio	30.80	2.30	0.04	1.33	1.13	0.00
Debt / EBITDA Ratio	-0.63	-0.73	-0.07	-1.43	-0.94	-0.01
Debt / FCF Ratio	-0.86	-1.17	-0.08	-1.52	-1.17	-0.01
Quick Ratio	2.92	4.34	10.05	1.53	1.66	18.51
Current Ratio	3.17	4.55	11.31	1.61	1.71	19.39
Asset Turnover	0.12	0.07	0.16	0.13	0	0
Interest Coverage	-11.85	-15.91	-10.27	-7.17	-13.07	-
Return on Equity (ROE)	-271.40%	-147.00%	-77.40%	-74.90%	-96.40%	-38.10%
Return on Assets (ROA)	-105.10%	-86.60%	-42.80%	-37.30%	-50.90%	-36.20%
Return on Capital (ROIC)	-161.14%	-100.74%	-51.24%	-40.66%	-57.24%	-46.13%
Earnings Yield	-25.48%	-21.76%	-21.67%	-13.92%	-14.34%	-6.89%
FCF Yield	-17.13%	-12.65%	-16.77%	-11.29%	-10.64%	-6.86%
Buyback Yield / Dilution	-8.04%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%
Total Shareholder Return	-8.04%	-32.72%	-26.32%	-8.20%	-0.39%	-69.80%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).